We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LITB:NYSELightInTheBox Holding Co., Ltd. Analysis

Data as of 2026-06-12 - not real-time

$3.60

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

LightInTheBox (LITB) is trading at $3.595, comfortably above its 20‑day SMA of 3.12 and its 50‑day SMA of 2.63, confirming a bullish price trend. The RSI sits at 68.8, just shy of overbought territory, while the MACD line (0.33) remains above its signal (0.30), adding momentum support. Fundamentals show a solid 10.5% revenue growth YoY, a robust 65% gross margin and a recent Q1 record profit of $1.2 M, driven by an 81% surge in branded apparel sales. Valuation metrics are strikingly low – a trailing P/E of 5.99, forward P/E of 3.99 and a price‑to‑sales of 0.29 – suggesting the stock may be undervalued despite a negative book value. However, the company reports zero operating cash flow, a negative equity base (PB = ‑23) and a historical max drawdown of ‑55%, while volatility is elevated at 77% over the past 30 days.
The market sentiment is extremely bullish (Fear‑Greed Index 88.18), but liquidity is thin (average volume ~11k vs today’s 6.1k) and beta is modest at 0.77, indicating limited systematic risk. Together, the technical upside, improving earnings narrative, and deep valuation discounts support a cautious buying case, tempered by cash‑flow weakness and high price volatility.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical setup (price above SMA20/50, bullish MACD)
  • Recent record profit and double‑digit revenue growth
  • Low valuation multiples (P/E ~6, P/S ~0.29)

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained apparel segment expansion (+81% YoY)
  • Continued margin stability (gross margin ~65%)
  • Undervalued price relative to earnings and sales

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Negative equity and zero operating cash flow raise solvency concerns
  • High price volatility (≈78% 30‑day) and thin trading volume
  • Potential for further upside if cash‑flow generation improves

Key Metrics & Analysis

Financial Health

Revenue Growth10.50%
Profit Margin4.07%
P/E Ratio6.0
ROA9.46%
P/B Ratio-23.2

Technical Analysis

TrendBullish
RSI68.8
Support$2.36
Resistance$3.89
MA 20$3.12
MA 50$2.63
MA 200$2.42
MACDBullish
VolumeDecreasing
Fear & Greed Index88.18

Valuation

GradeUndervalued
TypeBlend

Risk Assessment

Beta0.77
Volatility77.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.